References
- Xu X, Weiss S T, Rijcken B, Schouten J P. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. Eur Respir J 1994; 7(6)1056–1061, [PUBMED], [INFOTRIEVE]
- US Surgeon General. The Health Consequences of Smoking: Chronic Obstructive Lung Disease. US Dept of Heath and Human Research, 84‐50205. 1984
- Tager I B, Speizer F E. Risk estimates for chronic bronchitis in smokers: a study of male–female differences. Am J Respir Crit Care Med 1976; 113: 619–625
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77–S121, [CSA]
- Silverman E K, Chapman H A, Drazen J M, Weiss S T, Rosner B, Campbell E J, O'Donnell W J, Reilly J J, Ginns L, Mentzer S, Wain J, Speizer F E. Genetic epidemiology of severe, early‐onset chronic obstructive pulmonary disease. Am J Resp Crit Care Med 1998; 157: 1770–1778, [PUBMED], [INFOTRIEVE], [CSA]
- Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256–1276, [PUBMED], [INFOTRIEVE], [CSA]
- Piquette C A, Rennard S I, Snider G L. Chronic bronchitis and emphysema. Textbook of Respiratory Medicine3rd ed., J F Murray, J A Nadel. W.B. Saunders, Philadelphia, PA 2000; 1188–1245
- Barnes P J. Medical Progress: chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269–280, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Larson R K, Barman M L, Kueppers F, Fudenberg H H. Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Intern Med 1970; 72: 627–632, [PUBMED], [INFOTRIEVE]
- Kueppers F, Miller R D, Gordon H, Hepper N G, Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977; 63: 336–342, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cohen B H, Diamond E L, Graves C G, Kreiss P, Levy D A, Menkes H A, Permutt S. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 1977; ii: 523–526, [CROSSREF]
- Cohen B H. Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am. J Epidemiol 1980; 112: 274–288, [PUBMED], [INFOTRIEVE]
- Smith C AD, Harrison D J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350: 630–633, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cataldo D, Munaut C, Noel A, Frankenne F, Bartsch P, Foidart J M, Louis R. MMP‐2‐ and MMP‐9‐linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2000; 123: 259–267, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sanford A J, Chagani T, Weir T D, Connett J E, Anthonisen N R, Pare P D. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med 2001; 163: 469–473, [CSA]
- Poller W, Meisen C, Olek K. DNA polymorphisms of the alpha 1‐antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur J Clin Investig 1990; 20: 1–7, [CSA]
- Ishii T, Matsuse T, Teramoto S, Matsui H, Hosoi T, Fukuchi Y, Ouchi Y. Association between alpha 1‐antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease. Eur J Clin Investig 2000; 30: 543–548, [CROSSREF], [CSA]
- Poller W, Barth J, Voss B. Detection of an alternation of the α2‐macroglobulin gene in a patient with chronic lung disease and serum α2‐macroglobulin deficiency. Hum Genet 1989; 83: 93–96, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H. Microsatellite polymorphism in the heme oxygenase‐1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000; 55: 187–195, [CROSSREF]
- Huang S L, Su C H, Chang S C. Tumor necrosis factor–alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1436–1439, [PUBMED], [INFOTRIEVE], [CSA]
- Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, Takahashi H, Fukuchi Y, Ouchi Y. Glutathione S‐transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 693–696, [PUBMED], [INFOTRIEVE]
- Weiss S T, Segal M R, Tager I B, Tosteson T, Redline S, Speizer F E. Effects of asthma on pulmonary function in children: a longitudinal population‐based study. Am Rev Respir Dis 1992; 145: 58–64, [PUBMED], [INFOTRIEVE]
- Gold DR, Wypij D, Wang X, Speizer F E, Pugh M, Ware J H, Ferris B G, Jr, Dockery D W. Gender‐ and race‐specific effects of asthma and wheeze on level and growth of lung function in children in six US cities. Am J Respir Crit Care Med 1994; 149: 1198–1208, [PUBMED], [INFOTRIEVE], [CSA]
- Wang X, Mensinga T T, Schouten J P, Rijcken B, Weiss S T. Determinants of maximaly attained level of pulmonary function. Am J Respir Crit Care Med 2004; 169: 941–949, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shaheen S. The beginnings of chronic airflow obstruction. BMJ Bull 1970; 53: 58–70
- Shaheen S O, Barker D J, Shiell A W, Crocker F J, Wield G A, Holgate S T. The relationship between pneumonia in early childhood and impaired lung function in late adult life. Am J Respir Crit Care Med 1994; 149: 616–619, [PUBMED], [INFOTRIEVE], [CSA]
- Shaheen S O, Sterne J A, Florey C D. Birth weight, childhood lower respiratory tract infection, and adult lung function. Thorax 1998; 53: 549–553, [PUBMED], [INFOTRIEVE]
- Orie NG, Sluiter H J, Devries K. The host factor in bronchitis. Bronchitis, An International Symposium, N GM Orie, H J Sluiter. Assen, Netherlands 1961; 43–59
- Burrows B, Earle R H. Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients. N Engl J Med 1969; 280: 397–404, [PUBMED], [INFOTRIEVE]
- Rijken B, Scouten J P, Xu X, Rosner B, Weiss S T. Bronchial hyperresponsiveness to histamine is associated with accelerated decline in FEV1. Am J Respir Crit Care Med 1995; 151: 1377–1382, [CSA]
- Tracey M, Villar A, Dow L, Coggon D, Lampe F C, Holgate S T. The influence of increased bronchial responsiveness, atopy, serum IgE on decline in FEV1: a longitudinal study in the elderly. Am J Respir Crit Care Med 1995; 151: 656–662, [PUBMED], [INFOTRIEVE], [CSA]
- O'Connor G T, Sparrow D, Weiss S T. A prospective study of metacholine airway hyperresponsiveness as a predictor of pulmonary function decline: the Normative Aging Study. Am J Respir Crit Care Med 1995; 152: 87–92, [PUBMED], [INFOTRIEVE], [CSA]
- Postma D S, Kerstjens H AM. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: S187–S192, [PUBMED], [INFOTRIEVE], [CSA]
- Jeffrey P K. Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy 1999; 29(suppl 2)14–26, [CROSSREF]
- Saetta M, Turato G, Maestrelli P, Mapp C E, Fabbri L M. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1304–1309, [PUBMED], [INFOTRIEVE], [CSA]
- Fabbri L M, Romagnoli M, Corbetta L, Casoni G, Busljjetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 418–424, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Melbostad E, Eduard W, Magnus P. Chronic bronchitis in farmers. Scand J Work, Environ & Health 1997; 23: 271–280, [CSA]
- Davison A G, Fayers P M, Taylor A J, Venables K M, Darbyshire J, Pickering C A, Chettle D R, Franklin D, Guthrie C J, Scott M C. Cadmium fume inhalation and emphysema. Lancet 1988; 1: 663–667, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cowie R L, Mabena S K. Silicosis, chronic airflow limitation, and chronic bronchitis in South African gold miners. Am Rev Respir Dis 1991; 143: 80–84, [PUBMED], [INFOTRIEVE], [CSA]
- Christiani D C, Ye T T, Wegman D H, Eisen E A, Dai H L, Lu P L. Cotton dust exposure, across‐shift drop in FEV1, and five‐year change in lung function. Am J Respir Crit Care Med 1994; 150: 1250–1255, [PUBMED], [INFOTRIEVE], [CSA]
- Cowie R L. The influence of silicosis on deteriorating lung function in gold miners. Chest 1998; 113: 340–343, [PUBMED], [INFOTRIEVE]
- Morris A M, Huang L, Baccetti P, Turner J, Hopewell P C, Wallace J M, Kvale P A, Rosen M J. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus‐infected persons. The pulmonary complications of HIV infection study group. Am J Respir Crit Care Med 2000; 162: 612–616, [PUBMED], [INFOTRIEVE], [CSA]
- Diaz P T, King M A, Pacht E R, Wewers M D, Gadek J E, Nagaraja H N, Drake J, Clanton T L. Increased susceptibility to pulmonary emphysema among HIV‐seropositive smokers. Ann Intern Med 2000; 132: 369–372, [PUBMED], [INFOTRIEVE], [CSA]